2 – 5 November 2025

Join Avance Clinical at the CNS Summit 2025

Join Avance Clinical at the  CNS Summit 2025

Join Avance Clinical at the CNS Summit 2025

Avance Clinical is thrilled to announce our participation in the CNS Summit 2024, taking place from November 2 – 5 2025, in Boston, MA. The CNS Summit is a premier event dedicated to advancing clinical development and technology innovation in the Central Nervous System (CNS) therapeutic area. The Summit brings together a curated group of top decision makers from pharma, biotech, CROs, investigator sites, patient advocacy groups, investors and other stakeholders.

Our
expertise

22q11.2 Deletion Syndrome

Alzheimer’s

Amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Anxiety

Autism

Chemotherapy induced peripheral neuropathy

Duchenne muscular dystrophy

Epilepsy

Fibrodysplasia ossificans progressiva (FOP)

Fragile X

Frontotemporal Dementia (FTD)

GRIN disorder

Huntington’s disease

Hypoxic Ischemic Encephalopathy (HIE)

Major depressive disease (MDD)

Meningitis

Multiple sclerosis

Myasthenia gravis

Myotonic Dystrophy

Narcolepsy

Pain

Parkinson’s disease

Postoperative Delirium

Post-traumatic stress disorder (PTSD)

Recovery after stroke

Schizophrenia

Sleep apneoa

Spinal cord injury

Traumatic brain injury (TBI)

Treatment-resistant depression

Usher syndrome

Why Meet with Us?

The CNS Summit offers a unique opportunity to explore how Avance Clinical can support your CNS drug development programs. Our team is well-versed in the challenges and opportunities within the CNS therapeutic area, and we are eager to discuss how our comprehensive services can help accelerate your clinical trials. From early-phase trials to global regulatory strategies, Avance Clinical is your trusted partner in CNS drug development.

 

Schedule a Partnering Meeting

Don’t miss the opportunity to meet with our team of CNS clinical trial experts at CNS Summit. Whether you are exploring new CNS therapies or looking to optimize your clinical trial processes, our experts are here to provide insights and solutions tailored to your needs.

To arrange a partnering meeting, please contact us.

We look forward to seeing you in Boston and exploring how we can collaborate to advance your CNS therapeutic programs!

 

Find out more

Discover how CROs with in-house regulatory affairs deliver 30% savings, halve timelines, and cut risk for biotechs in the Frost & Sullivan report here.

Find out more about our GlobalReady program for biotechs looking to globalize their drug development strategy – watch the video now.

Book a meeting with us

Book a meeting
Terms and conditions

Related Events